Sanofi's planned consumer health spinoff picks up interest from multiple firms: Bloomberg
Fierce Pharma
FEBRUARY 21, 2024
As Sanofi continues to plot its planned separation from its consumer healthcare division, the business has reportedly attracted interest from multiple private equity firms. | Top buyout firms, including Advent International and Blackstone, have their eye on Sanofi's consumer health business, according to the news service.
Let's personalize your content